To further explore the correlation of clinicopathological variables between BRCA2 mutation-carriers and non-carriers with PCa, we extracted some impact factors including: GS, TNM stage, and risk stratification of PCa. This evidence concerns the gene BRCA2 and posterior cortical atrophy.